Literature DB >> 8882164

Potent inhibitory effects of steroids in an in vitro model of angiogenesis.

D C Jaggers1, W P Collins, S R Milligan.   

Abstract

The regulation of angiogenesis in the ovarian follicle and corpus luteum is unclear. Steroids are produced at very high concentrations in these tissues and we therefore examined the effect of steroids on angiogenesis in vitro. Explants of rat aorta were embedded in collagen gel and cultured in serum-free medium. Capillary-like microvessels were produced from the explants and microvessel number and length were measured in the presence and absence of steroids. At a concentration of 10 micrograms/ml, cortisol, progesterone, 17 alpha-hydroxyprogesterone and medroxyprogesterone acetate produced degeneration of microvessels after 7 days of steroid treatment (P < 0.01). Androstenedione and tetrahydro-S-(11-deoxytetrahydrocortisol) (tetrahydro S) produced degeneration at a slower rate: androstenedione inhibited microvessel growth after 11 days (P < 0.01) and tetrahydro S after 14 days (P < 0.05). Oestriol had no effect on microvessels; oestrone had a slow degenerative effect with significant inhibition seen after 14 days (P < 0.01). Oestradiol-17 beta at a concentration of 10 micrograms/ml completely inhibited microvessel growth from the explant cultures (P < 0.01) while at 1 microgram/ml it caused degenerative effects on growing microvessels. The effects of oestradiol and cortisol were reversible on removal of steroid-containing medium and replacement with 10% serum. We conclude that oestradiol may modulate angiogenesis in tissues in which the steroid concentration is high.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882164     DOI: 10.1677/joe.0.1500457

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

1.  Presence of oestrogen receptor type beta in human retina.

Authors:  C Munaut; V Lambert; A Noël; F Frankenne; M Deprez; J M Foidart; J M Rakic
Journal:  Br J Ophthalmol       Date:  2001-07       Impact factor: 4.638

2.  Hepatic cavernous hemangiomas: long-term (> 5 years) follow-up changes on contrast-enhanced dynamic computed tomography or magnetic resonance imaging and determinant factors of the size change.

Authors:  Jiae Choi; Jeong-Sik Yu; Eun-Suk Cho; Joo Hee Kim; Jae-Joon Chung
Journal:  Radiol Med       Date:  2018-01-22       Impact factor: 3.469

3.  Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis.

Authors:  D P Stevenson; S R Milligan; W P Collins
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

4.  Multiple liver hemangiomas enlargement during long-term steroid therapy for myasthenia gravis.

Authors:  T Takahashi; S Kuwao; H Katagiri; A Kakita
Journal:  Dig Dis Sci       Date:  1998-07       Impact factor: 3.199

5.  Hepatic haemangiomas: possible association with female sex hormones.

Authors:  V Glinkova; O Shevah; M Boaz; A Levine; H Shirin
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

6.  Thymidine phosphorylase activity and prodrug effects in a three-dimensional model of angiogenesis: implications for the treatment of ovarian cancer.

Authors:  D P Stevenson; W P Collins; F Farzaneh; K Hata; K Miyazaki
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.